Anthropic's Claude Finds CRISPR-Like Enzyme in Days — SkimNews

Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Anthropic announced its Bay Area wet biology lab discovered a new enzyme system with "properties reminiscent of CRISPR," hidden in the DNA of bacteriophages that infect bacteria.
- Claude completed the discovery in about 21 hours of concerted effort using roughly 950 agents that burned through 210 million tokens, even though the lab only opened this spring.
- CEO Dario Amodei said the discovery was "mostly, though not entirely" made by Claude, and acknowledged that a Stanford team had previously identified a system "in some ways similar."
- Anthropic's lab uses only human scientists for physical experiments, operates at BSL-1 and BSL-2 safety levels, and explicitly does not handle pathogens capable of infecting humans.
- Amodei said it may "eventually" be possible for Claude to autonomously run lab equipment "with appropriate safeguards," but stressed that is not happening today.
- AI-driven biology isn't exclusive to Anthropic — Stanford researchers are working with LLMs and CRISPR, UCSF used AI to design enzymes from scratch, and Google launched AlphaFold back in 2020.
Why it matters: Anthropic opened the lab earlier this year and already produced a discovery it considers meaningful — but every physical experiment was performed by human scientists, not Claude, despite Amodei's public belief that AI could one day "cure most diseases in 5-10 years." The timing cuts against the CEO's own recent calls for AI safety slowdowns and his stated fears about bioterrorism, making this a real-world test of whether Anthropic can accelerate biology research while staying inside the BSL-1 and BSL-2 guardrails it has voluntarily imposed.
Ask SkimNews




